Aurinia Pharmaceuticals
AUPH
AUPH
189 hedge funds and large institutions have $884M invested in Aurinia Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 58 increasing their positions, 55 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less ownership
Funds ownership: 33.86% → 29.87% (-4%)
8% less capital invested
Capital invested by funds: $958M → $884M (-$73.9M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
189
Holding in Top 10
1
Calls
$201M
Puts
$123M
Top Buyers
| 1 | +$21.8M | |
| 2 | +$21.7M | |
| 3 | +$18M | |
| 4 |
N
Natixis
Paris,
France
|
+$11.8M |
| 5 |
Renaissance Technologies
New York
|
+$11.1M |
Top Sellers
| 1 | -$85.5M | |
| 2 | -$49.8M | |
| 3 | -$46.2M | |
| 4 |
KPWS
Kestra Private Wealth Services
Austin,
Texas
|
-$17.7M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$11.5M |